An interventional study of Osteosynthesis with palmar locking plate and Osteosynthesis with external fixator in Colles' Fracture and Radius Fractures, sponsored by Heinrich-Heine University, Duesseldorf. Status unknown at 1 site in Germany. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2007-04-27.
Sponsored by Heinrich-Heine University, Duesseldorf · Not applicable, Interventional, and Treatment
This is a prospective, randomized, multi-center pilot study of unstable extraarticular fractures of the distal radius with dorsal displacement of the distal fragment in elderly patients. The patients are randomly assigned to osteosynthesis with palmar locking plate, external fixator, or Kirschner wires.
The aim of this pilot study is to allow a sample size calculation for a main randomized controlled trial (RCT). The primary outcome criterion is the functional status measured by the Disability of the Arm, Shoulder and Hand (DASH) questionnaire. Secondary outcome criteria are pain, range of motion (ROM), grip strength, and radiological parameters. Since this is a pilot study it is intended to generate a study hypothesis for the main RCT.
30 studies on the registry are indexed under Colles' Fracture; 4 are open to participants now.
This study's enrollment of 90 is above the median of 80 across 27 interventional studies indexed under Colles' Fracture.
Browse Colles' Fracture studies →Heinrich-Heine University, Duesseldorf is the lead sponsor of 174 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Functional status measured by DASH questionnaire
Pain
Range of motion (ROM)
Grip strength
Radiological parameters
Feasibility
This study is status unknown, as verified in Apr 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heinrich-Heine University, Duesseldorf